Melatonin Versus Placebo in Breast Cancer
NCT01805089
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
95
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Melatonin 3 mg
Sponsor
Dana-Farber Cancer Institute